The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Physical therapy exercises are crucial for properly recovering and healing from an injury. They are especially important for seniors who may have a longer road of recovery or need to regain mobility in order to take care of themselves. To help encourage patients to keep up with their exercises, startup BoBo Balance – led in part by company Co-founder and CMO and Technion alumnus Yair Agami – has transformed physical therapy into an interactive video game that allows users to earn points as they complete their regimen. Users can perform their exercises using a wearable movement sensor or on a…
An estimated 37 million people worldwide suffer from chronic kidney disease (CKD), with more than 2 million of them receiving dialysis as treatment. 90% of those on dialysis spend half their remaining lifetime hooked up to the machines and traveling to and from their dialysis clinic. In the interest of improving the quality of life for people with CKD, medical equipment manufacturer LiberDi has created an at-home system that could replace traditional in-clinic dialysis. Led in part by company CEO and Technion alumnus Hezekiah Tsoory, LiberDi’s Digital Dialysis Clinic uses peritoneal dialysis, a cheaper and less invasive method that utilizes…
Affective touch, or slow moving and low-force stimulation, has been shown to reduce feelings of stress and anxiety. But most of the time this requires another person to perform the brushing sensation, which makes the stress-reliever difficult to produce if someone is alone, at work, or in a public sphere. A new wearable device developed […]
Heart disease is the leading cause of death for both men and women, and one common complication of the condition is a buildup of fluid around the heart. Similarly, renal failure affects 2 million people worldwide, and also causes excess fluid retention in the body. Retaining fluids can cause capillary damage, swelling, breathing difficulties, and mobility problems, and current methods for treating this buildup can have negative side effects. To help solve this pressing issue, AquaPass Medical – founded and led in part by company CTO and Technion alumnus Yaacov Nitzan – has created a suit that comfortably removes fluid…
Heart failure affects more than 64 million people globally, making it one of the world’s greatest health challenges. Researchers at the Technion-affiliated Rambam Health Care Campus – Hospital are working to mitigate the prevalence of this disease. The hospital’s Heart Failure Unit, led by director and Technion alumnus Dr. Oren Caspi, has found a way […]
Did you know the average person encounters more than 60,000 germs every day? Different surfaces we touch, including countertops, remote controls, faucets, and phones harbor tons of bacteria we may not be aware of. What if a germ killer could be added to everyday items to help protect you and your health? Israeli startup Nanosono is doing exactly that. Led in part by COO and Technion alumnus Matan Benisty, the company has developed nanoparticles that can be embedded into paint, fabrics, plastics, and other materials to kill 99.999% of bacteria and viruses. Known as Quactiv, the germ killer is a…
Every year, more than 300,000 patients are placed on a ventilator because of respiratory distress that causes low blood oxygen levels. This number only grew during the COVID-19 pandemic with anywhere from 5% to 25% of COVID patients receiving ventilation care during their treatment in any given week. However, a new device created by Inspira Technologies – led in part by company CTO and Technion alumna Daniella Yeheskely-Hayon – could be a gamechanger for the treatment of oxygenation related issues. The device can boost a person’s oxygen levels immediately, reducing the need for ventilators and saving the patient from an…
The Technion Human Health Initiative Brings Medical Research and Technology to the Next Level It takes a village of scientists to tackle the increasingly complex health and medical issues of our time. The Technion is assembling a venture to do just that. Learn about the new Technion Human Health Initiative (THHI), a gathering of Technion […]
A total of 2% of children around the world are diagnosed with an autism spectrum disorder. Most struggle with clear communication and verbalization, making it difficult for the child to communicate their needs to others. An AI-powered app created by SocialMind Autism, led in part by Technion alumna and company CTO Dana Porrat, may hold the solution to this problem. The app gives parents and caregivers practical guidance on moments of attempted verbalization they may have otherwise overlooked, mainly targeting children under five as those years are the most critical in building language skills. SocialMind Autism gives personalized feedback within…
Pictured Above / L-R: Amir Livne, Dr. Gil Shamai and Prof. Ron Kimmel One in nine women globally will be diagnosed with breast cancer during their lifetime, and the numbers are only increasing as a result of factors, including increased lifespan and modern lifestyles. Personalized immunotherapy treatment is a necessity now more than ever, but the number of doctors and pathologists who specialize in examining tissue for specific diagnoses needed for personalized medicine is declining. To help combat this problem, Technion researchers have developed an artificial intelligence (AI) neural network that simplifies and improves the diagnostic process. Even better, the…
Imagine restaurant menus with selected dishes for men and others exclusively for women, or supermarket products categorized by gender. Looking even further into the future, what about designer 3D cultivated steaks that are male- or female-specific? Using simulated digestive systems, Technion scientists have identified differences in the way men and women digest food that could help tailor healthier food solutions by gender. The study, published recently in Food Hydrocolloids, was prompted by research recognizing that some medications are more effective in treating a specific gender, and that the same drug can have different side effects in men versus women. “We…
Valvular heart disease is the term used to describe when any valve in the heart is damaged or diseased. According to the U.S. Centers for Disease Control and Prevention, about 2.5% of the U.S. population has valvular heart disease – but it is more common in older adults. When any of the heart’s valves are diseased, they are unable to fully open or close to allow proper blood flow from one area of the heart to the next or in the correct direction it needs to move. In more severe cases, treatment can require open heart surgery. A new alternative…